Wednesday, Sep 28, 2022 | Last Update : 12:59 PM IST

bharat biotech

WHO suspends Covaxin supply to UN agencies

The suspension is in response to the outcomes of its post Emergency Use Authorisation inspection held between March 14-22, WHO said

03 Apr 2022 1:07 PM

Bharat Biotech gets DCGI nod for intranasal booster dose trials in India

The trials will be done at 9 different sites, with sources adding that the intranasal vaccine is likely to be launched by March

28 Jan 2022 2:22 PM

SEC approval for Bharat Biotech's COVID booster intranasal vaccine phase 3 trials

The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials

05 Jan 2022 1:15 PM

Bharat Biotech's partner seeks Covaxin approval in US for children below 18 years

The World Health Organisation on Wednesday granted approval for Emergency Use Listing Covaxin

06 Nov 2021 11:10 AM

WHO grants emergency use licence to Bharat Biotech's Covaxin

CDSCO has approved the extension of shelf life of Covaxin up to 12 months from the date of manufacture

03 Nov 2021 11:49 PM

ADVERTISEMENT

Drugs control committee extends shelf life of Bharat Biotech's Covaxin to 12 months

Currently, Covaxin has a shelf life of 6 months with subject to its storage at 2-8 degrees celsius

03 Nov 2021 3:52 PM

Bharat Biotech's Covaxin finds place in Oman's list of approved COVID-19 vaccines

All passengers who have received two doses of Covaxin atleast 14 days before the estimated arrival date can travel to Oman

28 Oct 2021 12:28 PM

Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials

Ocugen has already sought regulatory approval from Health Canada for Covaxin to be used in that country

27 Oct 2021 7:04 PM

WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin

The clarifications are sought to conduct a final 'risk-benefit assessment' for Emergency Use Listing of the vaccine

27 Oct 2021 8:06 AM

WHO to meet next week to consider emergency use listing of Covaxin

Hyderabad-based Bharat Biotech had submitted Expression of Interest on April 19 for its vaccine

18 Oct 2021 1:00 PM

ADVERTISEMENT

AA Edit | Validation glimmer for Covaxin, hope for parents

The two-dose vaccine will be administered with a gap of 28 days

14 Oct 2021 7:26 AM

Expert Committee recommends Covaxin for children, DCGI nod awaited

The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September

12 Oct 2021 1:42 PM

WHO to decide on Bharat Biotech's Covaxin emergency usage in October

The duration of the emergency use listing process depends on the quality of the data which is submitted by the vaccine manufacturer

30 Sep 2021 1:22 PM

Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18 years

On the production levels of Covaxin, Ella said 100 million doses per month can be possible

21 Sep 2021 2:24 PM

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process

17 Sep 2021 2:31 PM

ADVERTISEMENT

How tech can help India reach vaccine goals and slow down its COVID-19 disaster

India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain

30 Aug 2021 9:57 PM

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India

The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson

07 Aug 2021 2:37 PM

Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact

Termination of the MoU came after the deal with the Brazilian Government for supply of 20 million doses of Covaxin landed in controversy

27 Jul 2021 10:28 AM

India to miss end-July vaccination target as Bharat Biotech lags

The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August

27 Jul 2021 6:53 AM

Bharat Biotech's Covaxin trials suspended in Brazil after graft allegations

Bharat Biotech had on Friday announced cancellation of the MoU it signed for its COVID-19 vaccine Covaxin for the Brazilian market

24 Jul 2021 11:44 AM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT